Tempus AI stock forecast benefits from sector-wide tailwinds, with AI-driven medical platforms expected to expand at a CAGR of 25%, outpacing general tech growth rates in 2024–2026. Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. Jefferies downgrades Apple to “underperform,” calls iPhone sales expectations “excessive” Quantitative models in Tempus AI stock forecast predict a probable price range of +8% to +14% in the next 6 months, provided market sentiment in AI healthcare maintains current momentum.